文献速递腹部CTMRUS

胰腺导管腺癌漏诊与误判病例的相关因素分析

Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma.
PubMed 文献 · Eur Radiol · 2020-09-30

回顾性分析66/257例(26%)胰腺导管腺癌患者的107次影像检查,其中漏诊66/107(62%)、误判49/107(46%)。漏诊肿瘤多为小于2 cm、CT等密度或不改变轮廓;误判病例中59%被报告为无并发症胰腺炎。识别肿瘤固有特征、次要征象、技术因素及认知偏差有助于早期准确诊断。

要点

  • 胰腺导管腺癌漏诊率62%、误判率46%,CT等密度和小肿瘤是漏诊主因。
  • 次要征象中血管侵犯最易漏报(35/39,90%),需重点评估胰周血管。
  • 误判病例中59%被误报为胰腺炎,炎症改变可掩盖肿块或次要征象。

关键影像表现/征象

  • 漏诊肿瘤中45/107(42%)小于2 cm,32/72(44%)在CT上呈等密度,44/107(41%)不改变轮廓。
  • 94/107(88%)的检查显示次要征象,胰管扩张最常见(65/107,61%),血管侵犯最常被漏报(35/39,90%)。
  • 误判检查中29/49(59%)被报告为无并发症胰腺炎。

临床应用与阅片要点

  • 阅片时注意胰腺导管腺癌的固有肿瘤特征(如小于2 cm、CT等密度、不改变轮廓)以减少漏诊。
  • 报告中应关注次要征象,尤其是血管侵犯,需仔细评估胰周血管。
  • 避免将胰腺导管腺癌误判为胰腺炎,炎症改变可能掩盖肿块或次要征象。
  • 注意技术因素如对比剂剂量不足(CT和MRI中28/88,32%为次优对比剂剂量)及认知偏差如不注意盲(55/107,51%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To retrospectively examine US, CT, and MR imaging examinations of missed or misinterpreted pancreatic ductal adenocarcinoma (PDAC), and identify factors which may have confounded detection or interpretation.

METHODS: We reviewed 107 examinations in 66/257 patients (26%, mean age 73.7 years) diagnosed with PDAC in 2014 and 2015, with missed or misinterpreted imaging findings as determined by a prior study. For each patient, images and reports were independently reviewed by two radiologists, and in consensus, the following factors which may have confounded assessment were recorded: inherent tumor factors, concurrent pancreatic pathology, technical limitations, and cognitive biases. Secondary signs of PDAC associated with each examination were recorded and compared with the original report to determine which findings were missed.

RESULTS: There were 66/107 (62%) and 49/107 (46%) cases with missed and misinterpreted imaging findings, respectively. A significant number of missed tumors were < 2 cm (45/107, 42%), isoattenuating on CT (32/72, 44%) or non-contour deforming (44/107, 41%). Most (29/49, 59%) misinterpreted examinations were reported as uncomplicated pancreatitis. Almost all examinations (94/107, 88%) demonstrated secondary signs; pancreatic duct dilation was the most common (65/107, 61%) and vascular invasion was the most commonly missed 35/39 (90%). Of the CT and MRIs, 28 of 88 (32%) had suboptimal contrast dosing. Inattentional blindness was the most common cognitive bias, identified in 55/107 (51%) of the exams.

CONCLUSION: Recognizing pitfalls of PDAC detection and interpretation, including intrinsic tumor features, secondary signs, technical factors, and cognitive biases, can assist radiologists in making an early and accurate diagnosis.

KEY POINTS: • There were 66/107 (62%) and 49/107 (46%) cases with missed and misinterpreted imaging findings, respectively, with tumoral, technical, and cognitive factors leading to the misdiagnosis of pancreatic ductal adenocarcinoma. • The majority (29/49, 59%) of misinterpreted cases of pancreatic ductal adenocarcinoma were mistaken for pancreatitis, where an underlying mass or secondary signs were not appreciated due to inflammatory changes. • The most common missed secondary sign of pancreatic ductal adenocarcinoma was vascular encasement, missed in 35/39 (90%) of cases, indicating the importance of evaluating the peri-pancreatic vasculature.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kang JD, Clarke SE, Costa AF, et al. Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma. Eur Radiol. 2020. PMID: 32997176. doi:10.1007/s00330-020-07307-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。